Related references
Note: Only part of the references are listed.A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract
Francis K. L. Chan et al.
JOURNAL OF RHEUMATOLOGY (2010)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Francis K. L. Chan et al.
LANCET (2010)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
Matthew C. Becker et al.
AMERICAN HEART JOURNAL (2009)
Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design
Takahide Kohro et al.
HYPERTENSION RESEARCH (2009)
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
J. L. Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Loren Laine et al.
LANCET (2007)
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
A. Lanas et al.
GUT (2006)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Christopher P. Cannon et al.
LANCET (2006)
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study
G Singh et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo
JL Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
TJ Schnitzer et al.
LANCET (2004)
Development and validation of the pain treatment satisfaction scale (ptss):: a patient satisfaction questionnaire for use in patients with chronic or acute pain
CJ Evans et al.
PAIN (2004)
Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom
M Langman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
L Laine
GASTROENTEROLOGY (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
